Document information

34 votes

Role and immunomodulatory profile of histamine receptors by H1 and H2 antagonists

Trivendra Tripathi¹, Mohd. Shahid², Mashiatullah Siddiqui³, & Rahat Khan⁴

Correspondence: (Login to view email address)

1. J.N. Medical College & Hospital, Biochemistry
2. Aligarh Muslim University, Microbiology
3. Aligarh Muslim University, Biochemistry
4. Aligarh Muslim University, Pharmacology

PDF (113.3 KB)

Document Type:

Manuscript

Date:

Received 29 January 2008 10:31 UTC; Posted 29 January 2008

Subjects:

Immunology, Microbiology, Pharmacology

Tags:

• Histamine receptors
• immunomodulatory profile
• H1-antagonists
• H2-antagonists
• immunoregulation

Abstract:

The present study was designed to delineate the immunomodulatory role of histamine receptors (H1- and H2-) on induction of antibody response to sheep red blood cells (SRBC), as well as the antibody generation profile, in rabbit system, systemically. The rabbits in two groups received pheniramine (H1-receptor antagonist) and ranitidine (H2-receptor antagonist), respectively, via intramuscular route and were immunized with SRBC intravenously to evaluate suppression or enhancement of antibody responses in sem. A third, control group, received vehicle and were immunized in a similar manner. Histamine released from effector cells (mast cells and basophils) in vivo during inflammatory reactions could influence a detectable antibody response to SRBC as early as day 7-postimmunization (post-I), which lasted until day 28- post-I. Pheniramine-treated rabbits had significantly (*Pa ≤ 0.05 and **Pa ≤ 0.01) more suppressed total serum antibody (IgM + IgG) to SRBC as compared to ranitidine-treated ad cotrol rabbits, while ranitidine-treated rabbits showed different pattern (suppressed or enhanced) during the whole study period. Ranitidine suppressed total antibody level at days 7- and 14- post-I, and enhanced at days 21- and 28- post-I. IgM suppression at day 7- and enhancement at days 14-, 21- and 28- post-I, while IgG suppression during whole study period, as compared to control group was significant (*Pa ≤ 0.05 and **Pa ≤ 0.01) as assessed by direct hemagglutination assay* ad whole SBC-ELISA method**. Here we report that histamine receptor type 2 (H2R)-antagonists have a dominant role on immunosuppression and in immunoregulation of humoral immune responses. Histamine receptor type 2 (H2R)-antagonists are mainly involved in B cell differentiation and proliferation over histamine receptor type 1 (H1R)-antagonists.

Discussion

Votes:

34 votes

(Login to vote)

Comments:

0 comments

(Login to post a comment)

Share:

(Login to share with a colleague)

Additional information

License:

This document is licensed to the public under the Creative Commons Attribution 3.0 License

How to cite this document:

Tripathi, Trivendra, Shahid, Mohd., Siddiqui, Mashiatullah, and Khan, Rahat. Role and immunomodulatory profile of histamine receptors by H1 and H2 antagonists. Available from Nature Precedings <http://hdl.handle.net/10101/npre.2008.1547.1> (2008)

Version info:

Other versions of this document in Nature Precedings

None.

Other versions of this document elsewhere on the web

None known.

Submit a new version link